Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

Learn the crucial differences between Original Medicare and Medicare Advantage appeals, and discover expert strategies for ...

Major medical groups are proposing a major change to how doctors diagnose obesity.In Tuesday's issue of The Lancet Diabetes & ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

The difference is that Rybelsus is a pill, and Ozempic and Wegovy are at-home injections ... However, the rules on how you can qualify for that coverage will be different between insurance companies, ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...